about
Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary MyelofibrosisEvidence of Active Pro-Fibrotic Response in Blood of Patients with CirrhosisMatricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localizationTenascin-C drives persistence of organ fibrosis.Tenascin-C promotes migration of hepatic stellate cells and production of type I collagen.Suppression of hepatic dysfunction in tenascin‑X‑deficient mice fed a high‑fat diet.In wound repair vimentin mediates the transition of mesenchymal leader cells to a myofibroblast phenotype.
P2860
Q26774212-FCE33D6C-7DD1-42BB-A1CF-B04C71407ED6Q35759086-225CE21D-7B44-4092-A766-EF69F4F22F9BQ36578825-1CBF51DF-B422-4A02-A2A4-9BA12BD7AEC0Q36975903-D92998FD-9273-49DE-A873-FC591EC104DAQ39875332-D823F9B4-6414-41EE-ABD3-01A2AE690355Q42679429-3B6EB123-9B42-4482-9917-EF1EE11E940AQ54284559-051D4B7C-F9C6-4A13-B33A-64E47A0F2EC2
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tenascins in fibrotic disorders-from bench to bedside
@en
type
label
Tenascins in fibrotic disorders-from bench to bedside
@en
prefLabel
Tenascins in fibrotic disorders-from bench to bedside
@en
P2860
P1476
Tenascins in fibrotic disorders-from bench to bedside
@en
P2093
C Hammarström
M Kasprzycka
P2860
P356
10.4161/19336918.2014.994901
P577
2015-01-01T00:00:00Z